Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Future Outlook
- Macroeconomic Factors
- Global GDP Growth
- Demographic Factors
- Impact of U.S. Tariffs
- Porter's Five Forces Analysis
- Impact of AI Adoption on Clinical Trials Market
- Overview
- Use Cases/Case Studies
- Use Case 1: Oncology Patient Recruitment
- Use Case 2: Accelerating Data Processing in Infectious Disease Vaccine Trials
- Use Case 3: Enhancing Patient Retention in Alzheimer's Disease Trials
- AI Adoption: Clinical Trials
- Adoption Trends at Regional/Country Levels
- AI Disruption Trends
- Impact of AI on Industry Verticals
- Impact of AI on the Value Chain
- Market Spending and Investment
- Market Spending and Forecasting Analysis
- Venture Capital Investment in AI Focused on Clinical Trials
Chapter 3 Market Dynamics
- Market Drivers
- Need for a Faster Drug Development Process
- AI-driven Clinical Trials
- Advanced Data Handling for Complex Clinical Input
- Market Restraints
- Data Privacy and Security Concerns
- Regulatory Uncertainties
- High Costs and Technical Complexity
- Market Opportunities
- Accelerated Trials Through Adaptive AI Design
- AI-Augmented Remote Patient Monitoring
Chapter 4 Regulatory Landscape
Chapter 5 Emerging Technologies
- Overview
- Emerging Technologies
- Machine Learning for Predictive Analytics and Stratification
- Digital Twin Technology
- NLP for Extracting Insights from Unstructured Data
- AI-Powered Trial Design and Optimization
- Blockchain for Secure Clinical Data Management
- Decentralized and Virtual Trial Platforms
- Remote Monitoring Via Wearable Technologies
- Generative AI for Protocol Authoring
- Real-World Evidence Integration in Clinical Trials
- Cloud-based AI Platforms for Scalable Deployment
- Clinical Trial Analysis
- Takeaways
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Global Market for AI in Clinical Trials, by Component
- Takeaways
- Software
- Services
- Global AI in Clinical Trials Market, by Phase
- Takeaways
- Phase III
- Phase II Trials
- Phase I
- Phase IV Clinical Trials
- Global Market for AI in Clinical Trials, by Deployment Mode
- Takeaways
- Cloud
- On-premise
- Hybrid Deployments
- Global Market for AI in Clinical Trials, by Therapeutic Area
- Takeaways
- Oncology
- Infectious Disease Clinical Trials
- Neurological Diseases
- Other Conditions
- Global Market for AI in Clinical Trials, by End User
- Takeaways
- Pharmaceutical and Biotech Companies
- Contract Research Organizations
- Research and Academic Institutes
- Other End Users
- Geographic Breakdown
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
Chapter 7 Competitive Intelligence
Chapter 8 Sustainability in AI in Clinical Trials: ESG Perspective
- Sustainability Trends and AI Initiatives
- Concluding Remarks
List of Tables
Summary Table: Global Market for AI in Clinical Trials, by Region, Through 2030
Table 1: Real GDP Growth, by Country, 2022-2025
Table 2: Venture Capital Funding for U.S. Companies on AI for Clinical Trials
Table 3: VC Investment in AI Focused on Clinical Trials
Table 4: Regulations Pertaining to AI in Clinical Trials
Table 5: Clinical Trials Studies
Table 6: Global Market for AI in Clinical Trials, by Component, Through 2030
Table 7: Global Market for AI Software in Clinical Trials, by Region, Through 2030
Table 8: Global Market for Services Related to AI in Clinical Trials, by Region, Through 2030
Table 9: Global Market for AI in Clinical Trials, by Phase, Through 2030
Table 10: Global Market for AI in Phase III Clinical Trials, by Region, Through 2030
Table 11: Global Market for AI in Phase II Clinical Trials, by Region, Through 2030
Table 12: Global Market for AI in Phase I Clinical Trials, by Region, Through 2030
Table 13: Global Market for AI in Phase IV Clinical Trials, by Region, Through 2030
Table 14: Global Market for AI in Clinical Trials, by Deployment Mode, Through 2030
Table 15: Global Market for Cloud Deployments of AI in Clinical Trials, by Region, Through 2030
Table 16: Global Market for On-Premise Deployments of AI in Clinical Trials, by Region, Through 2030
Table 17: Global Market for Hybrid Deployments of AI in Clinical Trials, by Region, Through 2030
Table 18: Global Market for AI in Clinical Trials, by Therapeutic Area, Through 2030
Table 19: Global Market for AI in Oncology Clinical Trials, by Region, Through 2030
Table 20: Global Market for AI in Infectious Disease Clinical Trials, by Region, Through 2030
Table 21: Global Market for AI in Neurological Disease Clinical Trials, by Region, Through 2030
Table 22: Global Market for AI in Clinical Trials for Other Conditions, by Region, Through 2030
Table 23: Global Market for AI in Clinical Trials, by End User, Through 2030
Table 24: Global Market for AI Used in Clinical Trials by Pharmaceutical and Biotech Companies, by Region, Through 2030
Table 25: Global Market for AI Used in Clinical Trials by CROs, by Region, Through 2030
Table 26: Global Market for AI Used in Clinical Trials by Research and Academic Institutes, by Region, Through 2030
Table 27: Global Market for AI Used by Other End Users in Clinical Trials, by Region, Through 2030
Table 28: Global Market for AI in Clinical Trials, by Region, Through 2030
Table 29: North American Market for AI in Clinical Trials, by Component, Through 2030
Table 30: North American Market for AI in Clinical Trials, by Phase, Through 2030
Table 31: North American Market for AI in Clinical Trials, by Deployment Mode, Through 2030
Table 32: North American Market for AI in Clinical Trials, by Therapeutic Area, Through 2030
Table 33: North American Market for AI in Clinical Trials, by End User, Through 2030
Table 34: North American Market for AI in Clinical Trials, by Country, Through 2030
Table 35: European Market for AI in Clinical Trials, by Component, Through 2030
Table 36: European Market for AI in Clinical Trials, by Phase, Through 2030
Table 37: European Market for AI in Clinical Trials, by Deployment Mode, Through 2030
Table 38: European Market for AI in Clinical Trials, by Therapeutic Area, Through 2030
Table 39: European Market for AI in Clinical Trials, by End User, Through 2030
Table 40: European Market for AI in Clinical Trials, by Country, Through 2030
Table 41: Asia-Pacific Market for AI in Clinical Trials, by Component, Through 2030
Table 42: Asia-Pacific Market for AI in Clinical Trials, by Phase, Through 2030
Table 43: Asia-Pacific Market for AI in Clinical Trials, by Deployment Mode, Through 2030
Table 44: Asia-Pacific Market for AI in Clinical Trials, by Therapeutic Area, Through 2030
Table 45: Asia-Pacific Market for AI in Clinical Trials, by End User, Through 2030
Table 46: Asia-Pacific Market for AI in Clinical Trials, by Country, Through 2030
Table 47: MEA Market for AI in Clinical Trials, by Component, Through 2030
Table 48: MEA Market for AI in Clinical Trials, by Phase, Through 2030
Table 49: MEA Market for AI in Clinical Trials, by Deployment Mode, Through 2030
Table 50: MEA Market for AI in Clinical Trials, by Therapeutic Area, Through 2030
Table 51: MEA Market for AI in Clinical Trials, by End User, Through 2030
Table 52: MEA Market for AI in Clinical Trials, by Sub-Region, Through 2030
Table 53: South American Market for AI in Clinical Trials, by Component, Through 2030
Table 54: South American Market for AI in Clinical Trials, by Phase, Through 2030
Table 55: South American Market for AI in Clinical Trials, by Deployment Mode,Through 2030
Table 56: South American Market for AI in Clinical Trials, by Therapeutic Area,Through 2030
Table 57: South American Market for AI in Clinical Trials, by End User, Through 2030
Table 58: South American Market for AI in Clinical Trials, by Country, Through 2030
Table 59: Global Ranking of Players in AI in Clinical Trials Industry, 2024
Table 60: Strategic Initiatives, 2024 and 2025
Table 61: Information Sources Used in Preparing this Report
Table 62: Abbreviations Used in this Report
Table 63: AiCure: Company Snapshot
Table 64: AiCure: Product Portfolio
Table 65: AiCure: News/Key Developments, 2022
Table 66: ConcertAI: Company Snapshot
Table 67: ConcertAI: Product Portfolio
Table 68: ConcertAI: News/Key Developments, 2023 and 2024
Table 69: DNAnexus Inc.: Company Snapshot
Table 70: DNAnexus Inc: Product Portfolio
Table 71: DNAnexus Inc: News/Key Developments, 2024 and 2025
Table 72: Insilico Medicine: Company Snapshot
Table 73: Insilico Medicine: Product Portfolio
Table 74: Insilico Medicine: News/Key Developments, 2023-2025
Table 75: Intelligencia AI: Company Snapshot
Table 76: Intelligencia AI: Product Portfolio
Table 77: IQVIA: Company Snapshot
Table 78: IQVIA: Financial Performance, FY 2023 and 2024
Table 79: IQVIA: Product Portfolio
Table 80: IQVIA: News/Key Developments, 2025
Table 81: Medidata: Company Snapshot
Table 82: Medidata: Product Portfolio
Table 83: Medidata: News/Key Developments, 2023-2025
Table 84: Merative: Company Snapshot
Table 85: Merative: Product Portfolio
Table 86: Nvidia Corp.: Company Snapshot
Table 87: Nvidia Corp.: Financial Performance, FY 2023 and 2024
Table 88: Nvidia Corp.: Product Portfolio
Table 89: Nvidia Corp.: News/Key Developments, 2023-2025
Table 90: Phesi: Company Snapshot
Table 91: Phesi: Product Portfolio
Table 92: Phesi: News/Key Developments, 2022-2025
Table 93: Saama: Company Snapshot
Table 94: Saama: Product Portfolio
Table 95: Saama: News/Key Developments, 2023 and 2024
Table 96: Tempus: Company Snapshot
Table 97: Tempus: Product Portfolio
Table 98: Tempus: News/Key Developments, 2022-2025
Table 99: TriNetX LLC.: Company Snapshot
Table 100: TriNetX LLC: Product Portfolio
Table 101: TriNetX LLC: News/Key Developments, 2025
Table 102: Triomics: Company Snapshot
Table 103: Triomics: Product Portfolio
Table 104: Unlearn.ai Inc.: Company Snapshot
Table 105: Unlearn.ai Inc.: Product Portfolio
Table 106: Unlearn.ai Inc.: News/Key Developments, 2022 and 2025
Table 107: Emerging Startups
List of Figures
Summary Figure: Global Market Shares of AI in Clinical Trials, by Region, 2024
Figure 1: Porter’s Five Forces Analysis
Figure 2: Market Dynamics of Artificial Intelligence in Clinical Trials Market
Figure 3: Global Market Shares of AI in Clinical Trials, by Component, 2024
Figure 4: Global Market Shares of AI Software in Clinical Trials, by Region, 2024
Figure 5: Global Market Shares of Services Related to AI in Clinical Trials, by Region, 2024
Figure 6: Global Market Shares of AI in Clinical Trials, by Phase, 2024
Figure 7: Global Market Shares of AI in Phase III Clinical Trials, by Region, 2024
Figure 8: Global Market Shares of AI in Phase II Clinical Trials, by Region, 2024
Figure 9: Global Market Shares of AI in Phase I Clinical Trials, by Region, 2024
Figure 10: Global Market Shares of AI in Phase IV Clinical Trials, by Region, 2024
Figure 11: Global Market Shares of AI in Clinical Trials, by Deployment Mode, 2024
Figure 12: Global Market Shares of Cloud Deployments of AI in Clinical Trials, by Region, 2024
Figure 13: Global Market Shares of On-Premise Deployments of AI in Clinical Trials, by Region, 2024
Figure 14: Global Market Shares of Hybrid Deployments of AI in Clinical Trials, by Region, 2024
Figure 15: Global Market Shares of AI in Clinical Trials, by Therapeutic Area, 2024
Figure 16: Global Market Shares of AI in Oncology Clinical Trials, by Region, 2024
Figure 17: Global Market Shares of AI in Infectious Disease Clinical Trials, by Region, 2024
Figure 18: Global Market Shares of AI in Neurological Disease Clinical Trials, by Region, 2024
Figure 19: Global Market Shares of AI in Clinical Trials for Other Conditions, by Region, 2024
Figure 20: Global Market Shares of AI in Clinical Trials, by End User, 2024
Figure 21: Global Market Shares of AI Used in Clinical Trials by Pharmaceutical and Biotech Companies, by Region, 2024
Figure 22: Global Market Shares of AI Used in Clinical Trials by CROs, by Region, 2024
Figure 23: Global Market Shares of AI Used in Clinical Trials by Research and Academic Institutes, by Region, 2024
Figure 24: Global Market Shares of AI Used by Other End Users in Clinical Trials, by Region, 2024
Figure 25: Global Market Shares of AI in Clinical Trials, by Region, 2024
Figure 26: North American Market Shares of AI in Clinical Trials, by Country, 2024
Figure 27: European Market Shares of AI in Clinical Trials, by Country, 2024
Figure 28: Asia-Pacific Market Shares of AI in Clinical Trials, by Country, 2024
Figure 29: MEA Market Shares of AI in Clinical Trials, by Sub-Region, 2024
Figure 30: South American Market Shares of AI in Clinical Trials, by Country, 2024
Figure 31: IQVIA: Revenue Shares, by Business Unit, FY 2024
Figure 32: IQVIA: Revenue Shares, by Country/Region, FY 2024
Figure 33: Nvidia Corp.: Revenue Share, by Business Unit, FY 2024
Figure 34: Nvidia Corp.: Revenue Share, by Country/Region, FY 2024
